Is Medpace Holdings Stock Halal?
Table of Contents
How much of Medpace Holdings’ revenue comes from haram?
Medpace is a clinical contract research organization that provides services for the biotechnology, pharmaceutical, and medical device industries.
Medpace earns its revenue from the following revenue sources:
Medpace’s primary source of income is generated from research contracts. The company conducts clinical testing and research in the fields listed below.
- Oncology
- Metabolic
- Antiviral and Anti-infective (AVAI)
- Cardiology
- Central Nervous System
- Other Therapeutic Areas
The contributions from each of Medpace Holdings’ revenue segments in their 2020 annual report were as follows:
Practical Islamic Finance concludes:
None of Medpace Holdings’ revenue comes from anything inherently haram.
Does Medpace Holdings rely on interest to operate?
Year-to-Date for period ended 6/30/2021 | Fiscal year ended 12/31/2020 | Fiscal year ended 12/31/2019 | |
---|---|---|---|
Interest Income (Net) | – | $307 | – |
Total Revenue | $538,258 | $925,925 | $860,969 |
Interest Expense (Net) | $41 | – | $1,568 |
Total Expenses | $448,211 | $758,883 | $733,706 |
Interest Income / Revenue | – | 0.03% | – |
Interest Expense / Total Expense | 0.01% | – | 0.21% |
Practical Islamic Finance concludes:
Riba is used but not relied upon in Medpace Holdings’ operations.
What is Medpace Holdings’ Environmental, Social, and Governance (ESG) impact?
Environment
No notable environmental highlights.
Social
Medpace has a Glassdoor rating of 3.1 out of 5.0 from over 680 current and previous employees compared to a 3.3 average for all other Glassdoor rated companies.
Governance
No notable governance highlights.
Practical Islamic Finance concludes:
Medpace Holdings has a net positive ESG impact.
Comfort Rating
From Medpace Holdings’ business, financial, and ESG reviews, Practical Islamic Finance rates Medpace Holdings stock as: